Perfusion Measurement in Brain Gliomas with Intravoxel Incoherent Motion MRI

References

1. 1.↵
   The Central Brain Tumor Registry of the United States. http://www.cbtrus.org. Accessed November 11, 2012
2. 2.↵
   Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute. www.seer.cancer.gov. Accessed November 11, 2012
3. 3.↵
   1. Aronen HJ,
   2. Gazit IE,
   3. Louis DN,
   4. et al

   . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Law M,
   2. Yang S,
   3. Wang H,
   4. et al

   . Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98

   Abstract/FREE Full Text
5. 5.↵
   1. Law M,
   2. Young RJ,
   3. Babb JS,
   4. et al

   . Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490–98

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Kumar V,
   2. Abbas AK,
   3. Aster JC,
   4. et al

   . Robbins & Cotran Pathologic Basis of Disease. 7th ed. Paris, France: Elsevier Saunders; 2005
7. 7.↵
   1. Le Bihan D,
   2. Breton E,
   3. Lallemand D,
   4. et al

   . Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497–505

   PubMedWeb of Science
8. 8.↵
   1. Stejskal EO,
   2. Tanner JE

   . Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288–92

   CrossRefWeb of Science
9. 9.↵
   1. Le Bihan D,
   2. Turner R

   . The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 1992;27:171–78

   CrossRefPubMed
10. 10.↵
    1. Sumi M,
    2. Van Cauteren M,
    3. Sumi T,
    4. et al

    . Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology 2012;263:770–77

    CrossRefPubMed
11. 11.↵
    1. Lemke A,
    2. Laun FB,
    3. Klauss M,
    4. et al

    . Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest Radiol 2009;44:769–75

    CrossRefPubMed
12. 12.↵
    1. Chandarana H,
    2. Kang SK,
    3. Wong S,
    4. et al

    . Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest Radiol 2012;47:688–96

    CrossRefPubMed
13. 13.↵
    1. Sigmund EE,
    2. Cho GY,
    3. Kim S,
    4. et al

    . Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med 2011;65:1437–47

    CrossRefPubMed
14. 14.↵
    1. Henkelman RM,
    2. Neil JJ,
    3. Xiang QS

    . A quantitative interpretation of IVIM measurements of vascular perfusion in the rat brain. Magn Reson Med 1994;32:464–69

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Turner R,
    2. Le Bihan D,
    3. Maier J,
    4. et al

    . Echo-planar imaging of intravoxel incoherent motion. Radiology 1990;177:407–14

    PubMedWeb of Science
16. 16.↵
    1. Neil JJ,
    2. Bosch CS,
    3. Ackerman JJ

    . An evaluation of the sensitivity of the intravoxel incoherent motion (IVIM) method of blood flow measurement to changes in cerebral blood flow. Magn Reson Med 1994;32:60–65

    CrossRefPubMed
17. 17.↵
    1. Chenevert TL,
    2. Pipe JG,
    3. Williams DM,
    4. et al

    . Quantitative measurement of tissue perfusion and diffusion in vivo. Magn Reson Med 1991;17:197–212

    CrossRefPubMed
18. 18.↵
    1. Le Bihan D,
    2. Moonen CT,
    3. van Zijl PC,
    4. et al

    . Measuring random microscopic motion of water in tissues with MR imaging: a cat brain study. J Comput Assist Tomogr 1991;15:19–25

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Wirestam R,
    2. Brockstedt S,
    3. Lindgren A,
    4. et al

    . The perfusion fraction in volunteers and in patients with ischaemic stroke. Acta Radiol 1997;38:961–64

    FREE Full Text
20. 20.↵
    1. Federau C,
    2. Maeder P,
    3. O'Brien K,
    4. et al

    . Quantitative measurement of brain perfusion with intravoxel incoherent motion MR imaging. Radiology 2012;265:874–81

    CrossRefPubMed
21. 21.↵
    1. Seber GA,
    2. Wild CJ

    . Nonlinear Regression. Hoboken, New Jersey: Wiley-Interscience; 2003
22. 22.↵
    1. Le Bihan D,
    2. Turner R,
    3. MacFall JR

    . Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: applications to molecular diffusion imaging. Magn Reson Med 1989;10:324–37

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Wirestam R,
    2. Borg M,
    3. Brockstedt S,
    4. et al

    . Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique. Acta Radiol 2001;42:123–28

    FREE Full Text
24. 24.↵
    1. Andreou A,
    2. Koh DM,
    3. Collins DJ,
    4. et al

    . Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol 2013;23:428–34

    CrossRefPubMed
25. 25.↵
    1. Federau C,
    2. O'Brien K,
    3. Meuli R,
    4. et al

    . Measuring brain perfusion with intravoxel incoherent motion (IVIM): initial clinical experience. J Magn Reson Imaging 2013. In press
26. 26.↵
    1. Federau C,
    2. O'Brien K,
    3. Müller M,
    4. et al

    . Pulsatile microvascular perfusion demonstrated in the human brain with intravoxel incoherent motion (IVIM) MRI. In: Proceedings of the 21st Annual Meeting of the International Society for Magnetic Resonance in Medicine, Salt Lake City, Utah. April 20–26, 2013
27. 27.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Kochi M,
    4. et al

    . Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53–60

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Higano S,
    2. Yun X,
    3. Kumabe T,
    4. et al

    . Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006;241:839–46

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Murakami R,
    2. Sugahara T,
    3. Nakamura H,
    4. et al

    . Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007;243:493–99

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Scatliff JH,
    2. Radcliffe WB,
    3. Pittman HH,
    4. et al

    . Vascular structure of glioblastomas. Am J Roentgenol Radium Ther Nuclear Med 1969;105:795–805

    CrossRefPubMed
31. 31.↵
    1. Jain RK,
    2. di Tomaso E,
    3. Duda DG,
    4. et al

    . Angiogenesis in brain tumours. Nat Rev Neurosci 2007;8:610–22

    PubMedWeb of Science
32. 32.↵
    1. Calamante F,
    2. Gadian DG,
    3. Connelly A

    . Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002;33:1146–51

    Abstract/FREE Full Text
33. 33.↵
    1. Knutsson L,
    2. Stahlberg F,
    3. Wirestam R

    . Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities. MAGMA 2010;23:1–21

    CrossRefPubMed
34. 34.↵
    1. Petersen ET,
    2. Zimine I,
    3. Ho YC,
    4. et al

    . Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol 2006;79:688–701

    Abstract/FREE Full Text